The correlation of MBI symptoms with plasma Aβ42/Aβ40 (68) and plasma neurofilament light chain (NfL) (74), potential plasma biomarkers of AD, appear to reflect these associations. The gene discussed is NEFL; the disease is Alzheimer disease.